🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This 3 arm study will assess the tolerability, safety and efficacy of 3 neo...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00976989
Treatments Being Tested
The main objective of this randomized trial is to compare 6 FEC100 to 4 FEC...
Status
Unknown
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00189644
Treatments Being Tested
Previous studies in Western country show that triple-negative breast cancer...
Status
Completed
Location
Multiple Locations
Start Date
2011-01-01
Trial ID
NCT01216111
Treatments Being Tested
Primary Objectives: 1. To prospectively evaluate the predictive accuracy o...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2003-09
Trial ID
NCT00336791
Treatments Being Tested
Neoadjuvant chemotherapy, known as "first" or "induction chemotherapy" in t...
Status
Completed
Location
Hospital center
Start Date
2007-01
Trial ID
NCT00425516
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as fluorouracil, epirubicin, cy...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2004-05
Trial ID
NCT00087178
Treatments Being Tested
The goal of this clinical research study is to learn if using "gene signatu...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01159236
Treatments Being Tested
Various regimens and schedule as neoadjuvant chemotherapy regimens were inv...
Status
Completed
Location
Asan Medical Center
Start Date
2012-11
Trial ID
NCT02001506
Treatments Being Tested
The trial will determine the value of adding bevacizumab to chemotherapy pl...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2008-04
Trial ID
NCT00625898
Treatments Being Tested
This multicenter, non-randomized, open-label, phase 2 study is designed to ...
Status
Completed
Location
University of South Alabama; Mitchell Cancer Institute
Start Date
2014-07-14
Trial ID
NCT02132949
Treatments Being Tested